In diesem Buch stehen die kurz-, mittel- und langfristigen Risiken und Schäden psychiatrischer Psychopharmaka auf dem deutschsprachigen Markt (bis 1996) im Mittelpunkt, die sich im Muskelapparat, in den Organen und im vegetativen Bereich niederschlagen, z.
Integrating Psychological and Pharmacological Treatments for Addictive Disorders distills the complex literature on addiction, offering a curated toolbox of integrated pharmacological and psychotherapeutic treatments in chapters authored by leading experts.
Methods in Behavioral Pharmacology is unique in offering a complete description and critical evaluation of most, if not all, methods available to study the effects of drugs on behavior.
Psychopharmacological Agents, Volume IV summarizes the chemistry, pharmacology, and clinical manifestations of psychoactive drugs which are abused, with emphasis on opiate abuse and its treatment.
With examinations of 19 new psychiatric drugs, 19 new forms of previously available drugs, and a host of new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to include medical and psychiatric drugs that have become available since the publication of the second edition in 2017, as well as recent relevant randomized controlled trials, systematic reviews, and meta-analyses.
Clinical Manual of Addiction Psychopharmacology is a comprehensive guide to the pharmacology of drugs of abuse and the medications used to treat dependence on those substances.
Outlines a comprehensive, evidence-based approach to coordinating psychopharmacological and psychotherapeutic treatments Cognitive Behavioral Psychopharmacology takes an evidence-based approach to demonstrating the advantages of biopsychosocial integration in interventions for the major psychiatric diagnoses.
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose.
This text critically examines the shortcomings of psychiatry; the flawed development of the diagnostic system, including the DSM-5; and the failure to advance the effectiveness of antipsychotics and antidepressants.
Treating Disruptive Disorders is a practical book for busy clinicians-psychiatrists, psychologists, mental health counselors, clinical social workers, and more-as well as students, interns, or residents in the mental health professions.
A comprehensive overview of the associations between cannabis and mental illness, from basic sciences through to epidemiology and clinical perspectives.
TAKE AN ACTIVE ROLE IN YOUR MENTAL HEALTH Both easy to use and highly informative, The Complete Guide to Psychiatric Drugs is an indispensable reference for both patients and professionals.
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 44, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients.
This new, and heavily revised, edition of Psychopharmacology, provides a comprehensive scientific study of the effects of drugs on the mind and behavior.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation.
Uno de los retos que encontramos con los pacientes psicóticos, especialmente en los denominados "esquizofrénicos", es cómo ayudarles a que las experiencias que sienten como inefables las reconozcan como propias, puedan tolerarlas y verbalizarlas.
Early clinical intervention in psychosis is now a major objective of mental health services and the development of specialist intervention services has greatly facilitated research on the early phases of this disorder.
Part of the Drugs in series, the updated second edition of this practical pocketbook summarizes essential information on all the major drugs currently used in clinical psychiatric practice.
The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship.
This book comprehensively reviews the adverse effects of all commonly used older and newer antipsychotics and provides clinician-friendly monitoring resources and recommendations.
Concise, accessible summary of current knowledge about challenging behaviour, fully updated with expanded sections on emergence and prevention strategies.
Concise, accessible summary of current knowledge about challenging behaviour, fully updated with expanded sections on emergence and prevention strategies.
*; Details how psychedelics alter our experience from a neurological perspective, including what neurons they interact with, their effects on cognitive and emotional processing, and why those effects can be therapeutic*; Looks at clinical results with LSD, psilocybin from magic mushrooms, and DMT from ayahuasca, as well as empathogens such as MDMA, found in ecstasy*; Provides an illustrated introduction to neuroscience and a vision for a new model of psychotherapy where psychedelics help bring lasting healingPresenting a comprehensive guide to the new and evolving landscape of psychedelic-assisted mental health treatment, neuroscientist Irene de Caso takes you on a journey through the brain, revealing how psychedelics and empathogens, if taken in a safe and therapeutic environment, can lead to positive and lasting changes.
This book offers an in indictment of the nation's drug enforcement approach focusing on the short-sighted policies that often deny patients suffering from chronic pain the medications they need.
Early clinical intervention in psychosis is now a major objective of mental health services and the development of specialist intervention services has greatly facilitated research on the early phases of this disorder.
An evidence-based approach to psychopharmacology addressing the questions of optimal first line interventions, maintenance pharmacotherapy and management of treatment-refractory patients.
This new, and heavily revised, edition of Psychopharmacology, provides a comprehensive scientific study of the effects of drugs on the mind and behavior.
